Figures & data
Figure 1 Illustrations of ginsenoside compound-K-based mixed micelles and their mode of action for enhanced antitumor efficacy.
Abbreviaiton: Casp, caspase.
![Figure 1 Illustrations of ginsenoside compound-K-based mixed micelles and their mode of action for enhanced antitumor efficacy.Abbreviaiton: Casp, caspase.](/cms/asset/948665ef-4ee7-4110-a993-ba6148820879/dijn_a_12194124_f0001_c.jpg)
Figure 2 Particle size (A), transmission electron microscope image (B), zeta-potential (C) of CK mixed micelles and their release in vitro (D).
![Figure 2 Particle size (A), transmission electron microscope image (B), zeta-potential (C) of CK mixed micelles and their release in vitro (D).](/cms/asset/dd08affa-8794-40d1-90cc-4b82636dc7cb/dijn_a_12194124_f0002_c.jpg)
Figure 3 Anticancer effect of CK and CK mixed micelles to A549 cells. Cell proliferation assay (A), cell-cycle analysis assay (B), and wound-healing assay (C) of A549 cells.
Note: Green= G1, brown= S, and blue= G2 phase in B.
![Figure 3 Anticancer effect of CK and CK mixed micelles to A549 cells. Cell proliferation assay (A), cell-cycle analysis assay (B), and wound-healing assay (C) of A549 cells.Note: Green= G1, brown= S, and blue= G2 phase in B.](/cms/asset/ce210d13-991a-45da-9f58-99f7efb171e6/dijn_a_12194124_f0003_c.jpg)
Figure 4 Apoptotic bodies (A) and apoptosis ratio (B) were determined for qualitative and quantitative analysis.
![Figure 4 Apoptotic bodies (A) and apoptosis ratio (B) were determined for qualitative and quantitative analysis.](/cms/asset/4fca6049-cc37-4758-8e72-ba5e0c6e0a2c/dijn_a_12194124_f0004_c.jpg)
Figure 5 The uptake (A) and location (B) of PC/DP micelles observed in A549 cells. The tumor targeting effect of PC/DP micelles obtained in vivo (C).
![Figure 5 The uptake (A) and location (B) of PC/DP micelles observed in A549 cells. The tumor targeting effect of PC/DP micelles obtained in vivo (C).](/cms/asset/eeb46cdb-ceaa-4622-8bcc-96c7468ca710/dijn_a_12194124_f0005_c.jpg)